Dr. Michael Greenberg talks to Katie MacFarlane, President and CEO of Xintria Pharmaceutical Corporation about the FDA and its involvement in the birth of a new medication and the different rules that vitamins and herbal medications have regarding therapeutic claims.
The Birth of a Drug: Regulatory Factors in Vitamin and Herbal Therapy Claims
Share
Save
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Dr. Michael Greenberg talks to Katie MacFarlane, President and CEO of Xintria Pharmaceutical Corporation about the FDA and its involvement in the birth of a new medication and the different rules that vitamins and herbal medications have regarding therapeutic claims.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?